Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -15.46% is 222% below its 5-year average of -4.81%, near the low end of its 5-year range (-23.96%–12.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.76% above its 12-month average of -17.93%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -15.46%.
RETURN ON EQUITY (ROE)
-15.46%
RETURN ON EQUITY (ROE) AVG TTM
-17.93%
RETURN ON EQUITY (ROE) AVG 3Y
-4.02%
RETURN ON EQUITY (ROE) AVG 5Y
-4.81%
RETURN ON EQUITY (ROE) AVG 10Y
1.27%
RETURN ON EQUITY (ROE) AVG 15Y
-1.21%
RETURN ON EQUITY (ROE) AVG 20Y
-0.98%
CURRENT VS TTM AVG
+13.76%
CURRENT VS 3Y AVG
-284.32%
CURRENT VS 5Y AVG
-221.65%
CURRENT VS 10Y AVG
-1313.47%
CURRENT VS 15Y AVG
-1174.57%
CURRENT VS 20Y AVG
-1480.56%
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 630 covered companies
CURRENT VS SECTOR MEDIAN
+61.55%
vs the sector median at left
OraSure Technologies, Inc.
Market Cap
$267.83M
Return on Equity (ROE)
-15.46%
TTM Avg
-17.93%
3Y Avg
-4.02%
5Y Avg
-4.81%
Market Cap
$267.87M
Return on Equity (ROE)
-184.27%
TTM Avg
-57.34%
3Y Avg
-61.84%
5Y Avg
-87.31%
Market Cap
$267.51M
Return on Equity (ROE)
-38.33%
TTM Avg
-61.68%
3Y Avg
-393.03%
5Y Avg
-278.88%
Market Cap
$266.71M
Return on Equity (ROE)
-39.55%
TTM Avg
-28.46%
3Y Avg
-79.02%
5Y Avg
-63.95%
Market Cap
$261.87M
Return on Equity (ROE)
-37.12%
TTM Avg
-62.34%
3Y Avg
-32.67%
5Y Avg
8.91%
Market Cap
$274.62M
Return on Equity (ROE)
-4.68%
TTM Avg
-68.17%
3Y Avg
-57.88%
5Y Avg
-49.64%
Market Cap
$261.24M
Return on Equity (ROE)
-26.24%
TTM Avg
-102.84%
3Y Avg
-107.17%
5Y Avg
-107.44%
Market Cap
$277.05M
Return on Equity (ROE)
-5.95%
TTM Avg
-61.29%
3Y Avg
-64.14%
5Y Avg
-41.58%
Market Cap
$277.46M
Return on Equity (ROE)
-82.12%
TTM Avg
-62.12%
3Y Avg
-56.53%
5Y Avg
-50.41%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OraSure Technologies, Inc. (OSUR) | $267.83M | -15.46% | -17.93% | -4.02% | -4.81% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.87M | -184.27% | -57.34% | -61.84% | -87.31% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $267.51M | -38.33% | -61.68% | -393.03% | -278.88% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $266.71M | -39.55% | -28.46% | -79.02% | -63.95% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $261.87M | -37.12% | -62.34% | -32.67% | 8.91% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $274.62M | -4.68% | -68.17% | -57.88% | -49.64% |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | -26.24% | -102.84% | -107.17% | -107.44% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $277.05M | -5.95% | -61.29% | -64.14% | -41.58% |
| Fate Therapeutics, Inc. (FATE)vs › | $277.46M | -82.12% | -62.12% | -56.53% | -50.41% |
| AC Immune S.A. (ACIU)vs › | $256.77M | -124.67% | -101.06% | -69.44% | -56.33% |
ROE
-15.5%
ROA
-13.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -15.46% |
| 2026-03-31 | -23.96% |
| 2025-12-31 | -20.17% |
| 2025-09-30 | -16.64% |
| 2025-06-30 | -13.40% |
| 2025-03-31 | -8.06% |
| 2024-12-31 | -4.75% |
| 2024-09-30 | 2.67% |
| 2024-06-30 | 6.35% |
| 2024-03-31 | 5.36% |
| 2023-12-31 | 12.46% |
| 2023-09-30 | 12.20% |
| 2023-06-30 | 11.12% |
| 2023-03-31 | 7.62% |
| 2022-12-31 | -4.70% |
| 2022-09-30 | -12.67% |
| 2022-06-30 | -18.58% |
| 2022-03-31 | -12.80% |
| 2021-12-31 | -6.04% |
| 2021-09-30 | -2.77% |
| 2021-06-30 | 1.31% |
| 2021-03-31 | -0.95% |
| 2020-12-31 | -3.74% |
| 2020-09-30 | -3.70% |
| 2020-06-30 | -0.60% |
| 2020-03-31 | 4.34% |
| 2019-12-31 | 5.42% |
| 2019-09-30 | 8.13% |
| 2019-06-30 | 6.78% |
| 2019-03-31 | 6.87% |
| 2018-12-31 | 7.20% |
| 2018-09-30 | 6.29% |
| 2018-06-30 | 5.69% |
| 2018-03-31 | 6.33% |
| 2017-12-31 | 11.99% |
| 2017-09-30 | 12.36% |
| 2017-06-30 | 13.65% |
| 2017-03-31 | 14.23% |
| 2016-12-31 | 10.61% |
| 2016-09-30 | 9.71% |
| 2016-06-30 | 7.33% |
| 2016-03-31 | 6.44% |
| 2015-12-31 | 5.12% |
| 2015-09-30 | 0.56% |
| 2015-06-30 | 0.36% |
| 2015-03-31 | 0.73% |
| 2014-12-31 | -2.91% |
| 2014-09-30 | 2.64% |
| 2014-06-30 | 0.76% |
| 2014-03-31 | -4.26% |
| 2013-12-31 | -6.94% |
| 2013-09-30 | -15.02% |
| 2013-06-30 | -15.41% |
| 2013-03-31 | -13.81% |
| 2012-12-31 | -8.87% |
| 2012-09-30 | -5.23% |
| 2012-06-30 | -10.74% |
| 2012-03-31 | -9.47% |
| 2011-12-31 | -8.82% |
| 2011-09-30 | -10.40% |
| 2011-06-30 | -5.72% |
| 2011-03-31 | -3.86% |
| 2010-12-31 | -3.40% |
| 2010-09-30 | -5.15% |
| 2010-06-30 | -3.71% |
| 2010-03-31 | -8.24% |
| 2009-12-31 | -7.53% |
| 2009-09-30 | -32.37% |
| 2009-06-30 | -36.68% |
| 2009-03-31 | -32.52% |
| 2008-12-31 | -28.87% |
| 2008-09-30 | -1.43% |
| 2008-06-30 | -0.15% |
| 2008-03-31 | 2.09% |
| 2007-12-31 | 1.77% |
| 2007-09-30 | 2.53% |
| 2007-06-30 | 4.14% |
| 2007-03-31 | 4.43% |
| 2006-12-31 | 4.07% |
| 2006-09-30 | 19.53% |
| 2006-06-30 | 21.47% |
| 2006-03-31 | 22.16% |
| 2005-12-31 | 23.08% |
| 2005-09-30 | 7.47% |
| 2005-06-30 | 3.05% |
| 2005-03-31 | 1.50% |
| 2004-12-31 | -0.74% |
| 2004-09-30 | 0.16% |
| 2004-06-30 | 0.62% |
| 2004-03-31 | -0.28% |
| 2003-12-31 | -1.54% |
| 2003-09-30 | -5.89% |
| 2003-06-30 | -8.06% |
